Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.03 -0.29 (-1.89%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Operating Expenses (2013 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) reported Operating Expenses of $289 million for Q2 2026, up 5.1% from $275 million a year earlier but down 5.2% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Operating Expenses (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ultragenyx Pharmaceutical's Operating Expenses came in at $1.25 billion, up 11.7% year-over-year; for FY2025, it came in at $1.21 billion, up 10.2% from FY2024.

  • Operating Expenses has a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $1.1 billion in FY2024 (+9.3%), $1 billion in FY2023 (-0.9%), $1.01 billion in FY2022 (+38.1%) and $733.14 million in FY2021 (+22.0%).
  • Five-year quarterly Operating Expenses spans a low of $171.48 million in Q3 2021 and a high of $330.82 million in Q3 2025.
  • Year over year, Operating Expenses has now increased in each of the last ten quarters, with growth averaging 10.1% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q3 2022 (growth of 84.1%); the low point was Q3 2023 (a decline of 23.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $305 million (Q1 2026), $320.56 million (Q4 2025) and $330.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.12 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.56 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -9.70 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.20 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.09 Bn
10 Ultragenyx Pharmaceutical 1.48 Bn -321.29 Mn 180.00 Mn 289.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 289.00 Mn
Mar 31, 2026 305.00 Mn
Dec 31, 2025 320.56 Mn
Sep 30, 2025 330.82 Mn
Jun 30, 2025 275.00 Mn
Mar 31, 2025 282.00 Mn
Dec 31, 2024 286.95 Mn
Sep 30, 2024 271.48 Mn
Jun 30, 2024 263.39 Mn
Mar 31, 2024 274.18 Mn
Dec 31, 2023 248.98 Mn
Sep 30, 2023 243.15 Mn
Jun 30, 2023 256.27 Mn
Mar 31, 2023 254.60 Mn
Dec 31, 2022 248.98 Mn
Sep 30, 2022 315.77 Mn
Jun 30, 2022 230.94 Mn
Mar 31, 2022 216.57 Mn
Dec 31, 2021 185.95 Mn
Sep 30, 2021 171.48 Mn
API Access

Ultragenyx Pharmaceutical Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=RARE&period=max&api_key=YOUR_API_KEY